Selective serotonin reuptake inhibitor exposure in pregnancy and neonatal adverse events

Archives of Pediatrics and Adolescent Medicine

Volumn 164, Issue 4, 2010, Pages 394-

  Dubnov Raz, Gal ^a   Koren, Gideon ^b   Finkelstein, Yaron ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; SEROTONIN TRANSPORTER;

BIRTH WEIGHT; BREATHING; DRUG EFFECT; DRUG EXPOSURE; ELECTROCARDIOGRAPHY; HUMAN; LETTER; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; CONGENITAL HEART MALFORMATION; ECHOCARDIOGRAPHY; HEART MURMUR; PREGNANCY OUTCOME; PREVALENCE; QT PROLONGATION; ANIMAL; CHEMICALLY INDUCED DISORDER; FEMALE; FETUS HEART; LONG QT SYNDROME; METABOLISM; MOUSE; MOUSE MUTANT; NEWBORN; NOTE; PRENATAL EXPOSURE;

ANIMALS; FEMALE; FETAL HEART; HUMANS; INFANT, NEWBORN; LONG QT SYNDROME; MICE; MICE, KNOCKOUT; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 77950958766     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2010.34     Document Type: Letter

References (3)

1. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009;163(10):949-954.
2. Dubnov-Raz G, Juurlink DN, Fogelman R, et al. Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns. Pediatrics. 2008;122(3):e710-e715.
3. Pavone LM, Spina A, Rea S, et al. Serotonin transporter gene deficiency is associated with sudden death of newborn mice through activation of TGF-β1 signaling. J Mol Cell Cardiol. 2009;47(5):691-697.